Rudern_Mitchell Luo on Unsplash_cut

Collaboration is key in Sarcomas

Sarcomas are rare and are also difficult to diagnose and treat. This leads to many and varying challenges for sarcoma patients, compared with more common cancers.

Collaboration can be challenging. Partners can gain strength from finding their common ground, sharing resources and working together, which they cannot do working apart or in competition.

Patient advocacy in cooperation with experts and their medical/scientific societies can be a valuable partnership. This is more important in rarer cancers such as sarcomas. Collaboration is valuable for everyone.

Medical Societies

SPAGN continually strives to develop collaborations with other organizations and societies for the benefit of sarcoma patients.

We work with, or are members of, the following organizations:

Rare Cancers Europe

Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations. SPAEN is proud to be an active member of this valuable initiative.